Kristen Lee Arienti

Title: Kristen Lee Arienti: Innovator in Pharmaceutical Compounds

Introduction

Kristen Lee Arienti is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate steroid receptors. With a total of 2 patents, her work has the potential to impact various therapeutic areas.

Latest Patents

Arienti's latest patents include innovative compounds and methods for modulating processes mediated by steroid receptors. One of her notable patents focuses on androgen receptor modulator compounds and methods. This patent describes the preparation and use of non-steroidal compounds that act as agonists, partial agonists, and antagonists for the androgen receptor (AR). Additionally, it outlines methods for synthesizing critical intermediates, including a stereoselective synthetic route for AR modulators. Another significant patent involves piperazines as inhibitors of fructose-1,6-bisphosphatase (FBPase), detailing compounds with specific structural formulas.

Career Highlights

Throughout her career, Kristen has worked with reputable companies in the pharmaceutical industry, including Ligand Pharmaceuticals, Inc. and Ontogen Corporation. Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Kristen has collaborated with notable professionals in her field, including Robert Higuchi and Mani Neelakandha. These partnerships have further enhanced her research and development efforts.

Conclusion

Kristen Lee Arienti is a distinguished inventor whose work in pharmaceutical compounds showcases her innovative spirit and dedication to advancing medical science. Her contributions are poised to make a lasting impact in the industry.